HK1043736B - Contraceptive compositions containing antiprogestinic and progestinic - Google Patents

Contraceptive compositions containing antiprogestinic and progestinic Download PDF

Info

Publication number
HK1043736B
HK1043736B HK02104868.9A HK02104868A HK1043736B HK 1043736 B HK1043736 B HK 1043736B HK 02104868 A HK02104868 A HK 02104868A HK 1043736 B HK1043736 B HK 1043736B
Authority
HK
Hong Kong
Prior art keywords
substituted
alkyl
dihydro
oxazin
dimethyl
Prior art date
Application number
HK02104868.9A
Other languages
German (de)
English (en)
French (fr)
Chinese (zh)
Other versions
HK1043736A1 (en
Inventor
S. Grubb Gary
Zhi Lin
K. Jones Todd
M Tegley Christopher
P. Edwards James
A. Fletcher Horace
E. Wrobel Jay
Fensome Andrew
Zhang Puwen
A. Terefenko Eugene
Original Assignee
Wyeth
Ligand Pharmaceuticals Incorporated
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/552,350 external-priority patent/US6444668B1/en
Application filed by Wyeth, Ligand Pharmaceuticals Incorporated filed Critical Wyeth
Publication of HK1043736A1 publication Critical patent/HK1043736A1/en
Publication of HK1043736B publication Critical patent/HK1043736B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gynecology & Obstetrics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Display Devices Of Pinball Game Machines (AREA)
HK02104868.9A 1999-05-04 2000-05-01 Contraceptive compositions containing antiprogestinic and progestinic HK1043736B (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US30471299A 1999-05-04 1999-05-04
US304712 1999-05-04
US09/552,350 US6444668B1 (en) 1999-05-04 2000-04-19 Combination regimens using progesterone receptor modulators
US552350 2000-04-19
PCT/US2000/011643 WO2000066164A1 (en) 1999-05-04 2000-05-01 Contraceptive compositions containing antiprogestinic and progestinic

Publications (2)

Publication Number Publication Date
HK1043736A1 HK1043736A1 (en) 2002-09-27
HK1043736B true HK1043736B (en) 2005-04-01

Family

ID=26974177

Family Applications (1)

Application Number Title Priority Date Filing Date
HK02104868.9A HK1043736B (en) 1999-05-04 2000-05-01 Contraceptive compositions containing antiprogestinic and progestinic

Country Status (14)

Country Link
EP (1) EP1173210B1 (cg-RX-API-DMAC10.html)
JP (1) JP2002543155A (cg-RX-API-DMAC10.html)
CN (1) CN1179753C (cg-RX-API-DMAC10.html)
AT (1) ATE275973T1 (cg-RX-API-DMAC10.html)
AU (1) AU4682000A (cg-RX-API-DMAC10.html)
CA (1) CA2372773A1 (cg-RX-API-DMAC10.html)
DE (1) DE60013798T2 (cg-RX-API-DMAC10.html)
DK (1) DK1173210T3 (cg-RX-API-DMAC10.html)
ES (1) ES2226833T3 (cg-RX-API-DMAC10.html)
HK (1) HK1043736B (cg-RX-API-DMAC10.html)
MX (1) MXPA01011311A (cg-RX-API-DMAC10.html)
PT (1) PT1173210E (cg-RX-API-DMAC10.html)
SI (1) SI1173210T1 (cg-RX-API-DMAC10.html)
WO (1) WO2000066164A1 (cg-RX-API-DMAC10.html)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002076953A1 (en) 2001-03-21 2002-10-03 Warner-Lambert Company Llc New spirotricyclic derivatives and their use as phosphodiesterase-7 inhibitors
AR040783A1 (es) 2002-10-11 2005-04-20 Ligand Pharm Inc 5-(1',1'-cicloaquil/alquenil) metiliden-1,2 -dihidro-5-h-cromeno [3,4- f] quiinolinas como compuestos moduladores selectivos de receptores de progesterona
TW200410968A (en) 2002-10-11 2004-07-01 Ligand Pharm Inc 5-cycloalkenyl 5H-chromeno[3,4-f]quinoline derivatives as selective progesterone receptor modulator compounds
AR047398A1 (es) * 2003-11-24 2006-01-18 Wyeth Corp Acoplamiento cruzado carbono- carbono catalizado por metales de transicion sobre soportes solidos
BRPI0510260A (pt) * 2004-04-27 2007-10-23 Wyeth Corp método para purificar um composto, e, kit farmacêutico
WO2006023158A2 (en) 2004-07-14 2006-03-02 Ligand Pharmaceuticals, Inc. Mineralocorticoid receptor modulator compounds and methods, and pharmaceutical compositions containing these compounds
WO2006010142A2 (en) 2004-07-14 2006-01-26 Ligand Pharmaceuticals, Inc. Mineralocorticoid receptor modulator compounds, processes for their preparation, and their use
EP1774970A1 (de) * 2005-10-13 2007-04-18 Bayer Schering Pharma AG Verfahren zur Herstellung eines einphasigen pharmazeutischen Präparates zur Therapie der dysfunktionellen uterinen Blutung, enthaltend Ethinylestradiol und Dienogest
DE102008022221A1 (de) * 2008-05-06 2009-11-12 Universität des Saarlandes Inhibitoren der humanen Aldosteronsynthase CYP11B2

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3733478A1 (de) * 1987-10-01 1989-04-13 Schering Ag Antigestagen- und antioestrogenwirksame verbindungen zur geburtseinleitung und zum schwangerschaftsabbruch sowie zur behandlung gynaekologischer stoerungen und hormonabhaengiger tumore
DE4330234A1 (de) * 1993-09-02 1995-03-09 Schering Ag Verwendung von Gestagenen und kompetitiven Progesteronantagonisten zur Herstellung von Arzneimitteln für die weibliche Fertilitätskontrolle sowie Mittel enthaltend ein Gestagen und einen kompetitiven Progesteronantagonisten
DE4344463A1 (de) * 1993-12-22 1995-06-29 Schering Ag Kombinationsprodukt zur Kontrazeption
WO1996015794A1 (en) * 1994-11-22 1996-05-30 Balance Pharmaceuticals, Inc. Compositions and methods for contraception and for treatment of benign gynecological disorders
US5521166A (en) * 1994-12-19 1996-05-28 Ortho Pharmaceitical Corporation Antiprogestin cyclophasic hormonal regimen
ATE213947T1 (de) * 1996-06-25 2002-03-15 Akzo Nobel Nv Progestogen-anti-progestogen therapien

Also Published As

Publication number Publication date
CN1179753C (zh) 2004-12-15
AU4682000A (en) 2000-11-17
ES2226833T3 (es) 2005-04-01
DK1173210T3 (da) 2005-01-24
WO2000066164A1 (en) 2000-11-09
MXPA01011311A (es) 2003-07-14
PT1173210E (pt) 2005-01-31
DE60013798T2 (de) 2005-09-29
HK1043736A1 (en) 2002-09-27
WO2000066164A8 (en) 2001-05-03
SI1173210T1 (en) 2005-02-28
ATE275973T1 (de) 2004-10-15
DE60013798D1 (de) 2004-10-21
EP1173210A1 (en) 2002-01-23
CA2372773A1 (en) 2000-11-09
CN1349415A (zh) 2002-05-15
JP2002543155A (ja) 2002-12-17
EP1173210B1 (en) 2004-09-15

Similar Documents

Publication Publication Date Title
US7488822B2 (en) Cyclocarbamate derivatives as progesterone receptor modulators
US6444668B1 (en) Combination regimens using progesterone receptor modulators
US6436929B1 (en) Cyclothiocarbamate derivatives as progesterone receptor modulators
US6498154B1 (en) Cyclic regimens using quinazolinone and benzoxazine derivatives
EP1175411B1 (en) Cyclothiocarbamate derivatives as progesterone receptor modulators
EP1173210B1 (en) Contraceptive compositions containing antiprogestinic and progestinic
AU766428B2 (en) Cyclocarbamate derivatives as progesterone receptor modulators
CA2371651A1 (en) Quinazolinone and benzoxazine derivatives as progesterone receptor modulators

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20080501